Diazepam-induced place preference conditioning: Appetitive and antiaversive properties View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1985-10

AUTHORS

Christina Spyraki, Anna Kazandjian, Denis Varonos

ABSTRACT

The place conditioning paradigm was used to examine the reinforcing properties of diazepam. Rats were injeccted with diazepam (0.5–5.0 mg/kg, IP) and 30 min later were confined for 30 min to one side of a shuttle box, in which each of the two compartments had distinctive features. On alternate (control) days they received vehicle injections and were confined for 30 min to the opposite side. At almost all doses tested, diazepam produced place preference for the distinctive compartment that had been previously associated with the drug. Preference for the drug side developed regardless of whether diazepam was paired or unpaired with the least-preferred side, and regardless of whether testing was carried out in the undrugged or in the drugged state. The rats preferred the drug side over a novel compartment, but they did not change their initial preference for the side when diazepam was given after removal from the training box.Animals injected with meprobamate (70 mg/kg, PO), a non-benzodiazepine anxiolytic, also developed conditioned preference for the drug side, comparable to that seen following cocaine hydrochloride (10 mg/kg, IP).The diazepam (2.5 mg/kg)-induced place preference was antagonized by CGS 8216 (3 mg/kg, IP), picrotoxin (2 mg/kg, IP) and naloxone (0.8 mg/kg, SC), injected 3 min before and 15 and 20 min after diazepam respectively. Sodium valproate (200 mg/kg, IP) did not influence diazepam (1 mg/kg)-induced place preference. Sodium valproate by itself had marginal effects on place conditioning. Picrotoxin and naloxone, but not CGS 8816, produced place aversion which, in the case of picrotoxin, was due to state dependent learning. The results provide a clear indication that the place preference paradigm is valid as a test for evaluating appetitive properties of minor tranquilizers. They suggest that the rewarding effects of diazepam are mediated through central benzodiazepine receptors. Wheter GABA and/or endogenous opioid peptides are involved in the reinforcing properties of diazepam remains an open question. More... »

PAGES

225-232

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/bf00431813

DOI

http://dx.doi.org/10.1007/bf00431813

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1037647400

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/3931151


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1109", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Neurosciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Animals", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Appetitive Behavior", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Avoidance Learning", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cocaine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Conditioning, Operant", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Convulsants", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diazepam", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Meprobamate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Naloxone", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Picrotoxin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrazoles", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Rats, Inbred Strains", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Valproic Acid", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Department of Experimental Pharmacology, Medical School, University of Athens, Goudi, 11527, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/grid.5216.0", 
          "name": [
            "Department of Experimental Pharmacology, Medical School, University of Athens, Goudi, 11527, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Spyraki", 
        "givenName": "Christina", 
        "id": "sg:person.013575214644.23", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013575214644.23"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Experimental Pharmacology, Medical School, University of Athens, Goudi, 11527, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/grid.5216.0", 
          "name": [
            "Department of Experimental Pharmacology, Medical School, University of Athens, Goudi, 11527, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kazandjian", 
        "givenName": "Anna", 
        "id": "sg:person.0755144547.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755144547.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Experimental Pharmacology, Medical School, University of Athens, Goudi, 11527, Athens, Greece", 
          "id": "http://www.grid.ac/institutes/grid.5216.0", 
          "name": [
            "Department of Experimental Pharmacology, Medical School, University of Athens, Goudi, 11527, Athens, Greece"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Varonos", 
        "givenName": "Denis", 
        "id": "sg:person.015753174474.52", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015753174474.52"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf00427782", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025414090", 
          "https://doi.org/10.1007/bf00427782"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00428166", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004941568", 
          "https://doi.org/10.1007/bf00428166"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00432775", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013936851", 
          "https://doi.org/10.1007/bf00432775"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-1-4613-3967-0_7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1089517134", 
          "https://doi.org/10.1007/978-1-4613-3967-0_7"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00426529", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016008131", 
          "https://doi.org/10.1007/bf00426529"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00432169", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028227002", 
          "https://doi.org/10.1007/bf00432169"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/978-94-011-6203-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012543442", 
          "https://doi.org/10.1007/978-94-011-6203-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00421923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001920055", 
          "https://doi.org/10.1007/bf00421923"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.3758/bf03212315", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048253607", 
          "https://doi.org/10.3758/bf03212315"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00427827", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010557979", 
          "https://doi.org/10.1007/bf00427827"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00422097", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1010717551", 
          "https://doi.org/10.1007/bf00422097"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1985-10", 
    "datePublishedReg": "1985-10-01", 
    "description": "The place conditioning paradigm was used to examine the reinforcing properties of diazepam. Rats were injeccted with diazepam (0.5\u20135.0 mg/kg, IP) and 30 min later were confined for 30 min to one side of a shuttle box, in which each of the two compartments had distinctive features. On alternate (control) days they received vehicle injections and were confined for 30 min to the opposite side. At almost all doses tested, diazepam produced place preference for the distinctive compartment that had been previously associated with the drug. Preference for the drug side developed regardless of whether diazepam was paired or unpaired with the least-preferred side, and regardless of whether testing was carried out in the undrugged or in the drugged state. The rats preferred the drug side over a novel compartment, but they did not change their initial preference for the side when diazepam was given after removal from the training box.Animals injected with meprobamate (70 mg/kg, PO), a non-benzodiazepine anxiolytic, also developed conditioned preference for the drug side, comparable to that seen following cocaine hydrochloride (10 mg/kg, IP).The diazepam (2.5 mg/kg)-induced place preference was antagonized by CGS 8216 (3 mg/kg, IP), picrotoxin (2 mg/kg, IP) and naloxone (0.8 mg/kg, SC), injected 3 min before and 15 and 20 min after diazepam respectively. Sodium valproate (200 mg/kg, IP) did not influence diazepam (1 mg/kg)-induced place preference. Sodium valproate by itself had marginal effects on place conditioning. Picrotoxin and naloxone, but not CGS 8816, produced place aversion which, in the case of picrotoxin, was due to state dependent learning. The results provide a clear indication that the place preference paradigm is valid as a test for evaluating appetitive properties of minor tranquilizers. They suggest that the rewarding effects of diazepam are mediated through central benzodiazepine receptors. Wheter GABA and/or endogenous opioid peptides are involved in the reinforcing properties of diazepam remains an open question.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/bf00431813", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1085440", 
        "issn": [
          "0033-3158", 
          "1432-2072"
        ], 
        "name": "Psychopharmacology", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "87"
      }
    ], 
    "keywords": [
      "place preference", 
      "sodium valproate", 
      "drug side", 
      "endogenous opioid peptides", 
      "properties of diazepam", 
      "non-benzodiazepine anxiolytic", 
      "place conditioning paradigm", 
      "place preference paradigm", 
      "central benzodiazepine receptors", 
      "state dependent learning", 
      "vehicle injections", 
      "CGS 8216", 
      "place aversion", 
      "minor tranquilizers", 
      "rewarding effects", 
      "alternate days", 
      "place conditioning", 
      "appetitive properties", 
      "benzodiazepine receptors", 
      "opioid peptides", 
      "diazepam", 
      "drugged state", 
      "picrotoxin", 
      "preference paradigm", 
      "shuttle box", 
      "cocaine hydrochloride", 
      "naloxone", 
      "valproate", 
      "antiaversive properties", 
      "rats", 
      "dependent learning", 
      "conditioning paradigm", 
      "distinctive compartment", 
      "min", 
      "compartments", 
      "anxiolytics", 
      "GABA", 
      "doses", 
      "tranquilizers", 
      "drugs", 
      "meprobamate", 
      "receptors", 
      "injection", 
      "training box", 
      "initial preference", 
      "animals", 
      "days", 
      "marginal effect", 
      "indications", 
      "effect", 
      "clear indication", 
      "novel compartment", 
      "peptides", 
      "side", 
      "hydrochloride", 
      "opposite side", 
      "testing", 
      "conditioning", 
      "cases", 
      "test", 
      "preferences", 
      "removal", 
      "paradigm", 
      "distinctive features", 
      "features", 
      "aversion", 
      "results", 
      "open question", 
      "questions", 
      "state", 
      "box", 
      "properties", 
      "learning", 
      "CGS 8816", 
      "case of picrotoxin", 
      "Wheter GABA"
    ], 
    "name": "Diazepam-induced place preference conditioning: Appetitive and antiaversive properties", 
    "pagination": "225-232", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1037647400"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/bf00431813"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "3931151"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/bf00431813", 
      "https://app.dimensions.ai/details/publication/pub.1037647400"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2021-12-01T19:06", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_214.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/bf00431813"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf00431813'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf00431813'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf00431813'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf00431813'


 

This table displays all metadata directly associated to this object as RDF triples.

256 TRIPLES      22 PREDICATES      129 URIs      110 LITERALS      22 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/bf00431813 schema:about N0c7e62f8753a4b2f82f4a8d73c054fa2
2 N2880cbb67a91499e8397add4b5a0575b
3 N31fdb3c8f5814a73b139887eedc57c59
4 N353833db45ce42daa9fad1be86eb8203
5 N47e19526561140f9b5cfb70e754cf88d
6 N65c3d3d71e354ffda5d071e6e867c674
7 N6666f205869b4e96995df8eda22a3ea1
8 N7a5116c03b2e41a1aee0c259f89904f9
9 N9570864b36d448cda4474fc116b7dc6b
10 Na0e3d2435cf0460888c2eab1c93166c3
11 Na6f8ae6f85c44a4fa6e95b6ecaf13a22
12 Nb4263f6f289f43509e9b42aa80fa6409
13 Nc72fa217208f4c02859b0dc423637aff
14 Ncc745d0dcc8842b69c5ba808d94f3dfe
15 Ne628d88c852b439d88a45ae1b1dfb1f3
16 anzsrc-for:11
17 anzsrc-for:1109
18 schema:author Nad9af571afc84da8ac1b7ba230212a83
19 schema:citation sg:pub.10.1007/978-1-4613-3967-0_7
20 sg:pub.10.1007/978-94-011-6203-6
21 sg:pub.10.1007/bf00421923
22 sg:pub.10.1007/bf00422097
23 sg:pub.10.1007/bf00426529
24 sg:pub.10.1007/bf00427782
25 sg:pub.10.1007/bf00427827
26 sg:pub.10.1007/bf00428166
27 sg:pub.10.1007/bf00432169
28 sg:pub.10.1007/bf00432775
29 sg:pub.10.3758/bf03212315
30 schema:datePublished 1985-10
31 schema:datePublishedReg 1985-10-01
32 schema:description The place conditioning paradigm was used to examine the reinforcing properties of diazepam. Rats were injeccted with diazepam (0.5–5.0 mg/kg, IP) and 30 min later were confined for 30 min to one side of a shuttle box, in which each of the two compartments had distinctive features. On alternate (control) days they received vehicle injections and were confined for 30 min to the opposite side. At almost all doses tested, diazepam produced place preference for the distinctive compartment that had been previously associated with the drug. Preference for the drug side developed regardless of whether diazepam was paired or unpaired with the least-preferred side, and regardless of whether testing was carried out in the undrugged or in the drugged state. The rats preferred the drug side over a novel compartment, but they did not change their initial preference for the side when diazepam was given after removal from the training box.Animals injected with meprobamate (70 mg/kg, PO), a non-benzodiazepine anxiolytic, also developed conditioned preference for the drug side, comparable to that seen following cocaine hydrochloride (10 mg/kg, IP).The diazepam (2.5 mg/kg)-induced place preference was antagonized by CGS 8216 (3 mg/kg, IP), picrotoxin (2 mg/kg, IP) and naloxone (0.8 mg/kg, SC), injected 3 min before and 15 and 20 min after diazepam respectively. Sodium valproate (200 mg/kg, IP) did not influence diazepam (1 mg/kg)-induced place preference. Sodium valproate by itself had marginal effects on place conditioning. Picrotoxin and naloxone, but not CGS 8816, produced place aversion which, in the case of picrotoxin, was due to state dependent learning. The results provide a clear indication that the place preference paradigm is valid as a test for evaluating appetitive properties of minor tranquilizers. They suggest that the rewarding effects of diazepam are mediated through central benzodiazepine receptors. Wheter GABA and/or endogenous opioid peptides are involved in the reinforcing properties of diazepam remains an open question.
33 schema:genre article
34 schema:inLanguage en
35 schema:isAccessibleForFree false
36 schema:isPartOf N6d215230429044cd8d809f0ce5d97234
37 N9eaa403bfeca4cb68cc1efa6ae05c3c9
38 sg:journal.1085440
39 schema:keywords CGS 8216
40 CGS 8816
41 GABA
42 Wheter GABA
43 alternate days
44 animals
45 antiaversive properties
46 anxiolytics
47 appetitive properties
48 aversion
49 benzodiazepine receptors
50 box
51 case of picrotoxin
52 cases
53 central benzodiazepine receptors
54 clear indication
55 cocaine hydrochloride
56 compartments
57 conditioning
58 conditioning paradigm
59 days
60 dependent learning
61 diazepam
62 distinctive compartment
63 distinctive features
64 doses
65 drug side
66 drugged state
67 drugs
68 effect
69 endogenous opioid peptides
70 features
71 hydrochloride
72 indications
73 initial preference
74 injection
75 learning
76 marginal effect
77 meprobamate
78 min
79 minor tranquilizers
80 naloxone
81 non-benzodiazepine anxiolytic
82 novel compartment
83 open question
84 opioid peptides
85 opposite side
86 paradigm
87 peptides
88 picrotoxin
89 place aversion
90 place conditioning
91 place conditioning paradigm
92 place preference
93 place preference paradigm
94 preference paradigm
95 preferences
96 properties
97 properties of diazepam
98 questions
99 rats
100 receptors
101 removal
102 results
103 rewarding effects
104 shuttle box
105 side
106 sodium valproate
107 state
108 state dependent learning
109 test
110 testing
111 training box
112 tranquilizers
113 valproate
114 vehicle injections
115 schema:name Diazepam-induced place preference conditioning: Appetitive and antiaversive properties
116 schema:pagination 225-232
117 schema:productId N1fdc6142bfc84e6189e0893dbb1de30c
118 N93f0d44bdcb442029a735fcfe8b5ea6a
119 Nf404bf8f5cbe4859b31af8283a598005
120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037647400
121 https://doi.org/10.1007/bf00431813
122 schema:sdDatePublished 2021-12-01T19:06
123 schema:sdLicense https://scigraph.springernature.com/explorer/license/
124 schema:sdPublisher N584649cead37468c8168bfb7c8359617
125 schema:url https://doi.org/10.1007/bf00431813
126 sgo:license sg:explorer/license/
127 sgo:sdDataset articles
128 rdf:type schema:ScholarlyArticle
129 N0c7e62f8753a4b2f82f4a8d73c054fa2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
130 schema:name Male
131 rdf:type schema:DefinedTerm
132 N1fdc6142bfc84e6189e0893dbb1de30c schema:name doi
133 schema:value 10.1007/bf00431813
134 rdf:type schema:PropertyValue
135 N2880cbb67a91499e8397add4b5a0575b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Pyrazoles
137 rdf:type schema:DefinedTerm
138 N31fdb3c8f5814a73b139887eedc57c59 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
139 schema:name Diazepam
140 rdf:type schema:DefinedTerm
141 N353833db45ce42daa9fad1be86eb8203 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Rats, Inbred Strains
143 rdf:type schema:DefinedTerm
144 N47e19526561140f9b5cfb70e754cf88d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Animals
146 rdf:type schema:DefinedTerm
147 N584649cead37468c8168bfb7c8359617 schema:name Springer Nature - SN SciGraph project
148 rdf:type schema:Organization
149 N65c3d3d71e354ffda5d071e6e867c674 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
150 schema:name Meprobamate
151 rdf:type schema:DefinedTerm
152 N6666f205869b4e96995df8eda22a3ea1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
153 schema:name Appetitive Behavior
154 rdf:type schema:DefinedTerm
155 N6d215230429044cd8d809f0ce5d97234 schema:issueNumber 2
156 rdf:type schema:PublicationIssue
157 N7a5116c03b2e41a1aee0c259f89904f9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
158 schema:name Valproic Acid
159 rdf:type schema:DefinedTerm
160 N7e63114371fd4b30a70b0640db09a318 rdf:first sg:person.0755144547.36
161 rdf:rest Ndfc1021673c447f7a9ef61cf669e347a
162 N93f0d44bdcb442029a735fcfe8b5ea6a schema:name pubmed_id
163 schema:value 3931151
164 rdf:type schema:PropertyValue
165 N9570864b36d448cda4474fc116b7dc6b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
166 schema:name Conditioning, Operant
167 rdf:type schema:DefinedTerm
168 N9eaa403bfeca4cb68cc1efa6ae05c3c9 schema:volumeNumber 87
169 rdf:type schema:PublicationVolume
170 Na0e3d2435cf0460888c2eab1c93166c3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
171 schema:name Convulsants
172 rdf:type schema:DefinedTerm
173 Na6f8ae6f85c44a4fa6e95b6ecaf13a22 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
174 schema:name Avoidance Learning
175 rdf:type schema:DefinedTerm
176 Nad9af571afc84da8ac1b7ba230212a83 rdf:first sg:person.013575214644.23
177 rdf:rest N7e63114371fd4b30a70b0640db09a318
178 Nb4263f6f289f43509e9b42aa80fa6409 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
179 schema:name Naloxone
180 rdf:type schema:DefinedTerm
181 Nc72fa217208f4c02859b0dc423637aff schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
182 schema:name Cocaine
183 rdf:type schema:DefinedTerm
184 Ncc745d0dcc8842b69c5ba808d94f3dfe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
185 schema:name Picrotoxin
186 rdf:type schema:DefinedTerm
187 Ndfc1021673c447f7a9ef61cf669e347a rdf:first sg:person.015753174474.52
188 rdf:rest rdf:nil
189 Ne628d88c852b439d88a45ae1b1dfb1f3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
190 schema:name Rats
191 rdf:type schema:DefinedTerm
192 Nf404bf8f5cbe4859b31af8283a598005 schema:name dimensions_id
193 schema:value pub.1037647400
194 rdf:type schema:PropertyValue
195 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
196 schema:name Medical and Health Sciences
197 rdf:type schema:DefinedTerm
198 anzsrc-for:1109 schema:inDefinedTermSet anzsrc-for:
199 schema:name Neurosciences
200 rdf:type schema:DefinedTerm
201 sg:journal.1085440 schema:issn 0033-3158
202 1432-2072
203 schema:name Psychopharmacology
204 schema:publisher Springer Nature
205 rdf:type schema:Periodical
206 sg:person.013575214644.23 schema:affiliation grid-institutes:grid.5216.0
207 schema:familyName Spyraki
208 schema:givenName Christina
209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013575214644.23
210 rdf:type schema:Person
211 sg:person.015753174474.52 schema:affiliation grid-institutes:grid.5216.0
212 schema:familyName Varonos
213 schema:givenName Denis
214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015753174474.52
215 rdf:type schema:Person
216 sg:person.0755144547.36 schema:affiliation grid-institutes:grid.5216.0
217 schema:familyName Kazandjian
218 schema:givenName Anna
219 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0755144547.36
220 rdf:type schema:Person
221 sg:pub.10.1007/978-1-4613-3967-0_7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1089517134
222 https://doi.org/10.1007/978-1-4613-3967-0_7
223 rdf:type schema:CreativeWork
224 sg:pub.10.1007/978-94-011-6203-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012543442
225 https://doi.org/10.1007/978-94-011-6203-6
226 rdf:type schema:CreativeWork
227 sg:pub.10.1007/bf00421923 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001920055
228 https://doi.org/10.1007/bf00421923
229 rdf:type schema:CreativeWork
230 sg:pub.10.1007/bf00422097 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010717551
231 https://doi.org/10.1007/bf00422097
232 rdf:type schema:CreativeWork
233 sg:pub.10.1007/bf00426529 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016008131
234 https://doi.org/10.1007/bf00426529
235 rdf:type schema:CreativeWork
236 sg:pub.10.1007/bf00427782 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025414090
237 https://doi.org/10.1007/bf00427782
238 rdf:type schema:CreativeWork
239 sg:pub.10.1007/bf00427827 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010557979
240 https://doi.org/10.1007/bf00427827
241 rdf:type schema:CreativeWork
242 sg:pub.10.1007/bf00428166 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004941568
243 https://doi.org/10.1007/bf00428166
244 rdf:type schema:CreativeWork
245 sg:pub.10.1007/bf00432169 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028227002
246 https://doi.org/10.1007/bf00432169
247 rdf:type schema:CreativeWork
248 sg:pub.10.1007/bf00432775 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013936851
249 https://doi.org/10.1007/bf00432775
250 rdf:type schema:CreativeWork
251 sg:pub.10.3758/bf03212315 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048253607
252 https://doi.org/10.3758/bf03212315
253 rdf:type schema:CreativeWork
254 grid-institutes:grid.5216.0 schema:alternateName Department of Experimental Pharmacology, Medical School, University of Athens, Goudi, 11527, Athens, Greece
255 schema:name Department of Experimental Pharmacology, Medical School, University of Athens, Goudi, 11527, Athens, Greece
256 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...